article thumbnail

‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer

MedCity News

While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR T-therapy with properties that could improve safety, efficacy, and durability. Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia.

FDA 312
article thumbnail

Beyond Engineering: Integrating UX for Safer and More Efficient Medical Products

MedCity News

While the approach to patient and treatment safety is crucial, there is a notable shift towards processes centered around patients and healthcare professionals. The post Beyond Engineering: Integrating UX for Safer and More Efficient Medical Products appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nanoparticle drug delivery innovation could enhance drug development

European Pharmaceutical Review

can be engineered by selecting different biomolecules, metal ions and assembly conditions [providing] a modular approach to construct multifunctional nanoparticles with diverse compositions, stated Professor Frank Caruso, Department of Chemical Engineering, University of Melbourne, Australia.

article thumbnail

First patient receives new engineered mRNA epigenetic

European Pharmaceutical Review

As the first-ever Omega Epigenomic Controller (OEC) to be dosed in a patient, this milestone represents a significant step forward…to bringing engineered, programmable mRNA therapeutics to patients,” explained Mahesh Karande, President and Chief Executive Officer of Omega Therapeutics.

article thumbnail

Re-engineering proteins to develop novel immunotherapies

European Pharmaceutical Review

By re-engineering existing approaches that have already shown clinical promise, there is potential to bring further benefit to the patient community in its fight against cancer. Since then, several next-generation antibodies have been engineered with modifications that enable them to better engage with immune cells.

article thumbnail

Hetero Labs Limited-Walk-In Interviews for Quality Control/ Quality Assurance/ Engineering/ Safety -EHS On 29th Jan’ 2023

Pharma Pathway

Hetero Labs Limited-Walk-In Interviews for Quality Control/ Quality Assurance/ Engineering/ Safety -EHS On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Dear, Greetings from Hetero…!!

article thumbnail

Biological E. Limited- Hiring ITI/ Diploma/ B.Tech in Engineering Department -Send your Resume

Pharma Pathway

Limited- Hiring ITI/ Diploma/ B.Tech in Engineering Department -Send your Resume. Openings in Engineering Department. Limited- Hiring ITI/ Diploma/ B.Tech in Engineering Department -Send your Resume. Biological E. Job Description. Biological E. Designation: Officer/ Sr. Qualification: ITI/ Diploma/ B.Tech. Biological E.